Delivery Order SPE2DB22D2206-SPE2DB25FGV92

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $32K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $13,099.49. The contract is a Firm Fixed Price contract, with a period of performance through May 29, 2025. The contract is not set-aside and is open to full and open competition. Amerisourcebergen Drug Corp...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,962.50, is for the procurement of 4567444668 ! WEZLANA 90 MG/ML SYRINGEML medical supplies. The contract has an ultimate completion date of March 4, 2025. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price of $66,722.04 and a period of performance through June 5, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,568.57, is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a completion date of June 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of WEZLANA 90 MG/ML SYRINGE. The contract has a ceiling value of $29,561.01 and is a Firm Fixed Price type. It has an ultimate completion date of June 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4568077746 - WEZLANA 90 MG/ML SYRINGE/ML, a pharmaceutical product. The contract has a Firm Fixed Price pricing type, a ceiling value of $5,576.34, and a period of performance through April 30, 2025. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4567617054 ! WEZLANA 90 MG/ML SYRINGEML, a medical product, with a ceiling value of $5,568.57 and a period of performance ending on March 19, 2025. The contract is a Firm Fixed Price (FFP) delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $11,974.26. The contract is for the delivery of WEZLANA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a performance period ending on July 9, 2025 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. This contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $49,167.64 firm-fixed-price contract is for the supply of WEZLANA 90 MG/ML SYRINGE. The contract has an ultimate completion date of May 28, 2025. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of "WEZLANA 90 MG/ML SYRINGEML", a pharmaceutical product, with a firm fixed price ceiling value of $68,269.63. The contract has an ultimate completion date of June 6, 2025. This contract is not designated as a set-aside. Amerisourcebergen Drug Corporation holds a...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGV92
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568143127 WEZLANA 90 MG/ML SYRINGE. The contract has a firm fixed price of $31,769.95 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which provides comprehensive global pharmaceutical support to military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract is not set aside and is awarded through open competition.

Generated 8/4/25, 9:49 AM